Last reviewed · How we verify
Cumopyran (cyclocoumarol)
Cumopyran (generic name: cyclocoumarol) is a cyclocoumarol drug. It is currently in unknown development.
Cumopyran is thought to work by inhibiting an enzyme involved in blood clotting.
Cumopyran is a small molecule with synonyms including Cyclocoumarol and Cyclocoumarol.
At a glance
| Generic name | cyclocoumarol |
|---|---|
| Drug class | cyclocoumarol |
| Therapeutic area | Hematology |
| Phase | unknown |
Mechanism of action
Imagine your blood as a liquid that can flow freely, but when you get hurt, it needs to clot to stop the bleeding. Cumopyran is believed to help regulate this clotting process by blocking an enzyme that helps blood cells stick together. This can help prevent excessive clotting and reduce the risk of blood clots forming.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cumopyran CI brief — competitive landscape report
- Cumopyran updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Cumopyran
What is Cumopyran?
How does Cumopyran work?
What is the generic name of Cumopyran?
What drug class is Cumopyran in?
What development phase is Cumopyran in?
Related
- Drug class: All cyclocoumarol drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Hematology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing